E

Eisai Co.

Tokyo, Japan Founded 1941 TSE: 4523
Nanomedicine Drug Delivery Nanobiomarkers Nano-Bio Regenerative Medicine Protein Nanoparticles

About

Neurology and oncology with nanoformulation research

Company Details

Type
public
Employees
11000+
Funding
Public

Key Products

  • Leqembi
  • Lenvima
Visit Website

Related Companies

N

Nanosphere (Luminex)

Northbrook, United States

N

NanoString Technologies

Seattle, United States

N

Nanobiotix

Paris, France

A

Arrowhead Research

Pasadena, United States